Ascorbic acid, caffeine, ephedrine, thiamine, vitamin a (Be-leane Slimming)

Listings for this ingredient that could not be applied to this product

• S6: Ephedrine

  • except products registered in terms of the Act, not intended for export, and being oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer; (S2)
  • except preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine. (S1)

  Consolidated Schedules 06 July 2026, lines 10226 to 10235

• S3: Caffeine

  • when intended for injection.

  Consolidated Schedules 06 July 2026, line 3256

• S3: Vitamin b1

  • and derivatives thereof
  • in preparations thereof for injection; (S0)
  • except in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

  Consolidated Schedules 06 July 2026, lines 4392 to 4397

• S3: Vitamin c

  • in preparations thereof for injection; (S0)
  • except in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)

  Consolidated Schedules 06 July 2026, lines 4435 to 4440

• S2: Ephedrine

  • contained in products registered in terms of the Act, and not intended for export,
  • oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer; (S6)
  • except preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine. (S1)

  Consolidated Schedules 06 July 2026, lines 1899 to 1907

• S2: Vitamin a

  • and derivatives thereof and including retinol, retinal, retinoic acids and beta-carotene (but excluding isotretinoin) and not listed elsewhere in the Schedules, contained in preparations or mixtures containing more than 5 000 I.U (or 1 500 milligrams of the retinol equivalent or 3 000 milligrams of the beta-carotene equivalent) but not more than 10 000 I.U (or 3 000 milligrams of the retinol equivalent or 6 000 milligrams of the beta-carotene equivalent) of Vitamin A per recommended daily dose alone or in combination with other active pharmaceutical ingredients, except when registered in terms of the provisions of the Fertilizers, Farm Feeds, Agriculture Remedies and Stock Remedies Act, 1947 (Act 36 of 1947). (S0, S3)

  Consolidated Schedules 06 July 2026, lines 2755 to 2761

• S1: Ephedrine

  • preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine, and not intended for export; (S6)
  • except products registered in terms of the Act, not intended for export, and being oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer. (S2)

  Consolidated Schedules 06 July 2026, lines 410 to 419

• S1: Vitamin b1

  • and derivatives thereof
  • in oral preparations or mixtures containing more than 100 mg of Vitamin B1 per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
  • except in preparations thereof for injection. (S3)

  Consolidated Schedules 06 July 2026, lines 1149 to 1154

• S1: Vitamin c

  • in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
  • except in preparations thereof for injection. (S3)

  Consolidated Schedules 06 July 2026, lines 1184 to 1189

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.